Flash FinanceUS
After hours S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Twist Bioscience Corp (TWST)

Twist Bioscience files prospectus to register resale of shares held by Invenra

Neutral Impact 2 of 5 shareholder Written later

Twist Bioscience filed a prospectus supplement to register for resale shares issuable to Invenra Inc. under a Stock Purchase Agreement and Registration Rights Agreement, both dated February 11, 2026. The filing includes a legal opinion from Orrick, Herrington & Sutcliffe LLP, and the filing does not state the number of shares or any sale price. For shareholders, this is an administrative step that could allow Invenra to sell shares into the market.

Key points

  • Registration rights agreement and stock purchase agreement with Invenra Inc. are both dated February 11, 2026.
  • Company is filing a prospectus supplement to register resale of shares issuable under the stock purchase agreement.
  • Orrick, Herrington & Sutcliffe LLP opinion filed as Exhibit 5.1; the filing does not state the number of shares.

The filing

CompanyTwist Bioscience Corp (TWST)
Form8-K, current report
Filed with the SECAug 19, 2026, 5:24 PM ET
Accession number0001104659-26-098830

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 19, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.